![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.594, 2010-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etravirine for the treatment of HIV/AIDS
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Nanomedicines as Therapeutics in HIV-AIDS
Pharmaceutical Nanotechnology, Vol. 4, Iss. 4, 2016-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Access to HIV/AIDS drugs widens
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Funding boost for HIV/AIDS initiatives
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 358, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharma giants commit to HIV/AIDS effort
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 369, 2002-01 ,pp. :